Search - tctmd.com

Displaying 641 - 660 of 841

Sort: Relevancy | Date

News Daily News

New Syntax Tool Gauges Completeness of Revascularization, Predicts Prognosis

October 24, 2014

News Daily News

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

October 10, 2014

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

News Daily News

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

October 10, 2014

News Daily News

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Yael L. Maxwell

October 03, 2014

Presentation TCT 2014

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Patrick W. Serruys

September 16, 2014

Presentation TCT 2014

Definitely To Prevent Stent Thrombosis and MI!

Presenter: Gregg W. Stone

September 15, 2014

Presentation TCT 2014

Cangrelor III: Detailed Effects on Intraprocedural and Postprocedural Stent Thrombosis

Presenter: Christian W. Hamm, Franz-Josef Neumann, Philippe Généreux

September 15, 2014

Presentation TCT 2014

Case Study: Recurrent Stent Thrombosis

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini

September 14, 2014

Presentation TCT 2014

Hematologic Etiologies of Stent Thrombosis and How to Evaluate

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Giulio G. Stefanini

September 14, 2014

Presentation TCT 2014

Evaluation and Treatment of Stent Thrombosis: From Acute Patency to Long-term Vascular Stability

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Ron Waksman

September 14, 2014

Presentation TCT 2014

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

Presenter: Pieter C. Smits

September 14, 2014

Presentation TCT 2014

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Presenter: Evald H. Christiansen

September 14, 2014

Presentation TCT 2014

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

Presenter: Hyo-Soo Kim

September 14, 2014

Presentation TCT 2014

Bioresorbable Polymer-Based DES are the Right Choice to Minimize Stent Thrombosis!

Presenter: Stephan Windecker

September 14, 2014

Presentation TCT 2014

Are Current DES Really Safer Than BMS?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Tullio Palmerini

September 14, 2014

Presentation TCT 2014

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Marco Valgimigli

September 14, 2014

Presentation TCT 2014

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber

September 14, 2014

Presentation TCT 2014

Complication Case #2: Stent Thrombosis and Abrupt Closure

Presenter: Run-Lin Gao, Martin B. Leon, Gregg W. Stone, Qi Zhang

September 13, 2014

Presentation TCT 2014

Restenosis and Stent Thrombosis

Presenter: George D. Dangas, Kevin J. Croce

September 13, 2014

Advertisement

New Syntax Tool Gauges Completeness of Revascularization, Predicts Prognosis

研究探索了在氯吡格雷治疗的PCI患者中，糖尿病对血小板反应性的影响

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

Estudios Exploran el Impacto de la Diabetes sobre la Reactividad Plaquetaria en Pacientes PCI a Tratamiento con Clopodogrel

HORIZONS-AMI Substudy: Women at Higher Risk for Bleeding After STEMI

Left Main Stent Thrombosis: New Insights Into the Scope of the Problem

Definitely To Prevent Stent Thrombosis and MI!

Cangrelor III: Detailed Effects on Intraprocedural and Postprocedural Stent Thrombosis

Case Study: Recurrent Stent Thrombosis

Hematologic Etiologies of Stent Thrombosis and How to Evaluate

Evaluation and Treatment of Stent Thrombosis: From Acute Patency to Long-term Vascular Stability

TCT 642: Stent Thrombosis Rates with an Abluminal Biodegradable Polymer, Biolimus-Eluting Stent Versus a Durable Polymer, Everolimus-Eluting Stent in Patients Undergoing Percutaneous Coronary Intervention: 3-Year Follow-up from the COMPARE II Trial

TCT 643: Very Late Stent Thrombosis After Revascularization with the Biolimus-Eluting, Biodegradable Polymer-Coated Nobori Stent Versus Durable Polymer-Coated, Sirolimus-Eluting Stents from the SORT-OUT V Trial

Follow the Data: Fluorinated Polymer-Based DES are Safer than Bioresorbable-Based DES!

Bioresorbable Polymer-Based DES are the Right Choice to Minimize Stent Thrombosis!

Are Current DES Really Safer Than BMS?

Beyond the Guidelines: What Is the Optimal Duration of DAPT After Metallic DES Implantation, and Is It Device Specific?

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Complication Case #2: Stent Thrombosis and Abrupt Closure

Restenosis and Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content